CCGDF yields 2.49% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, CCGDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCGDF + JNJ for your $10,000?
China Cinda Asset Management Co., Ltd. acquires, manages, invests in, and disposes financial and non-financial institution distressed assets in the People's Republic of China. The company operates through Distressed Asset Management Business, and Financial Services Business segments. It is also involved in receivership; foreign investment; securities and futures dealing; financial bond issuance; inter-bank borrowing and lending; commercial financing for other financial institutions; approved asset securitization business; financial institutions custody; and closing and liquidation of business. In addition, the company engages in consulting and advisory business on finance, investment, and legal and risk management; asset and project evaluation; banking business; fund management; asset management; trust; financial leasing services; and real estate and industrial investments and other businesses. Further, it is involved in securities brokerage, real estate development, property leasing, hotel management, and aircraft leasing activities. The company serves customers through 33 branches. China Cinda Asset Management Co., Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.
Full CCGDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.